Champlin R - Search Results

1

Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Among authors: champlin r. Leuk Lymphoma. 1994 Sep;15(1-2):85-90. doi: 10.3109/10428199409051682. Leuk Lymphoma. 1994. PMID: 7858506

2

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.

Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. Schiller G, et al. Among authors: champlin r. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. Br J Haematol. 1992. PMID: 1643014 Clinical Trial.

3

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.

Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W. Champlin R, et al. J Clin Oncol. 1990 Jul;8(7):1199-206. doi: 10.1200/JCO.1990.8.7.1199. J Clin Oncol. 1990. PMID: 1694236 Clinical Trial.

4

Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.

Schiller G, Feig SA, Territo M, Wolin M, Lill M, Belin T, Hunt L, Nimer S, Champlin R, Gajewski J. Schiller G, et al. Among authors: champlin r. Br J Haematol. 1994 Sep;88(1):72-8. doi: 10.1111/j.1365-2141.1994.tb04979.x. Br J Haematol. 1994. PMID: 7803259

5

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Among authors: champlin r. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. Leuk Lymphoma. 1993. PMID: 8220156 Clinical Trial.

6

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R. Schiller G, et al. Among authors: champlin r. Blood. 1992 Dec 15;80(12):2977-82. Blood. 1992. PMID: 1467513 Free article. Clinical Trial.

7

Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

Champlin R, Ho W, Gajewski J, Feig S, Burnison M, Holley G, Greenberg P, Lee K, Schmid I, Giorgi J, et al. Champlin R, et al. Blood. 1990 Jul 15;76(2):418-23. Blood. 1990. PMID: 2142440 Free article.

8

Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.

Champlin R, Gajewski J, Feig S, Giorgi J, Lyddane N, Lee K, Schmidt I, Winston D, Ho W, Reichert T. Champlin R, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):2947-8. Transplant Proc. 1989. PMID: 2495694 No abstract available.

9

Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation.

Champlin R, Ho W, Winston D, Decker R, Greenberg P, Burnison M, Holly FE, Gale RP. Champlin R, et al. Semin Oncol. 1987 Jun;14(2 Suppl 1):1-6. Semin Oncol. 1987. PMID: 2438775 No abstract available.

10

High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.

Champlin R, Jacobs A, Gale RP, Ho W, Selch M, Lenarsky C, Feig SA. Champlin R, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):190-5. Semin Oncol. 1985. PMID: 3892702 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,179 results

Search Page

Filters